Accolade Inc logo

ACCD - Accolade Inc Share Price

$40.68 2.7  7.1%

Last Trade - 8:05pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.36bn
Enterprise Value £1.35bn
Revenue £93.9m
Position in Universe 1883rd / 6368
Bullish
Bearish
Unlock ACCD Revenue
Momentum
Relative Strength (%)
1m +20.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.89%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 28th Feb 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 76.8 94.8 159.1 +23.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 November 2019, Accolade Inc revenues increased 47% to $88.1M. Net loss decreased 1% to $49.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Depreciation and amortization decrease of 7% to $6.4M (expense), Stock-based Compensation in decrease of 12% to $2.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ACCD Revenue Unlock ACCD Revenue

Net Income

ACCD Net Income Unlock ACCD Revenue

Normalised EPS

ACCD Normalised EPS Unlock ACCD Revenue

PE Ratio Range

ACCD PE Ratio Range Unlock ACCD Revenue

Dividend Yield Range

ACCD Dividend Yield Range Unlock ACCD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ACCD EPS Forecasts Unlock ACCD Revenue
Profile Summary

Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). It leverages its integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population. The Company’s offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits and Accolade Boost.

Directors
Last Annual February 28th, 2019
Last Interim November 30th, 2019
Incorporated January 23, 2007
No. of Shareholders: n/a
No. of Employees: 1,174
Sector Healthcare
Industry Healthcare Providers & Services
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 47,001,258
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ACCD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ACCD
Upcoming Events for ACCD
Thursday 13th August, 2020
Q1 2021 Accolade Inc Earnings Release
Thursday 13th August, 2020
Q1 2021 Accolade Inc Earnings Call
Frequently Asked Questions for Accolade Inc
What is the Accolade Inc share price?

As of 8:05pm, shares in Accolade Inc are trading at $40.68, giving the company a market capitalisation of £1.36bn. This share price information is delayed by 15 minutes.

How has the Accolade Inc share price performed this year?

Shares in Accolade Inc are currently trading at $40.68 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Accolade Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Accolade Inc?

There are no analysts currently covering Accolade Inc.

When will Accolade Inc next release its financial results?

Accolade Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-11-30
What is the Accolade Inc dividend yield?

Accolade Inc does not currently pay a dividend.

Does Accolade Inc pay a dividend?

Accolade Inc does not currently pay a dividend.

When does Accolade Inc next pay dividends?

Accolade Inc does not currently pay a dividend.

How do I buy Accolade Inc shares?

To buy shares in Accolade Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Accolade Inc?

Shares in Accolade Inc are currently trading at $40.68, giving the company a market capitalisation of £1.36bn.

Where are Accolade Inc shares listed? Where are Accolade Inc shares listed?

Here are the trading details for Accolade Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ACCD
What kind of share is Accolade Inc?

Based on an overall assessment of its quality, value and momentum, Accolade Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Accolade Inc share price forecast 2020?

Shares in Accolade Inc are currently priced at $40.68. At that level they are trading at 2.71% discount to the analyst consensus target price of 0.00.

How can I tell whether the Accolade Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Accolade Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $40.68, shares in Accolade Inc are trading at 14.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Accolade Inc PE Ratio?

We were not able to find PE ratio data for Accolade Inc.

Who are the key directors of Accolade Inc?

Accolade Inc's management team is headed by:

Bruno Bonnell - CHM
Denis Guyennot - PRE
David Fremed - CFO
Rajeev Singh - CEO
Stephen Barnes - CFO
Robert Cavanaugh - PRE
J. Michael Cline - CHM
William Frist - IND
Jeffrey Jordan - IND
Peter Klein - IND
Dawn Lepore - IND
James Madden - IND
Britt Provost - EVP
Phong Nguyen - EVP
Matt Eurey - EVP
Richard Eskew - EVP
Beverly Gibson - EVP
Todd Clardy - EVP
Who are the major shareholders of Accolade Inc?

Here are the top five shareholders of Accolade Inc based on the size of their shareholding:

Cline (J Michael) Individual Investor
Percentage owned: 21.55% (10.1m shares)
Accretive Investors SBIC, L.P. Corporation
Percentage owned: 21.55% (10.1m shares)
Carrick Capital Partners Investment Advisor
Percentage owned: 7.46% (3.51m shares)
AH Parallel Fund IV LP Corporation
Percentage owned: 7.21% (3.39m shares)
Comcast Ventures Venture Capital
Percentage owned: 5.52% (2.60m shares)
Similar to ACCD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.